Selskabets formål er forskning og udvikling af lægemidler, samt dermed beslægtet virksomhed
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -4.6 mio. | -7.5 mio. | 5.3 mio. | 4.1 mio. | 0 | |
CVR: 42057428
Secondary names: DolorestBio ApS
Previous names: DolorestBio ApS
Marigold Innovation ApS registered with 15% ownership
IFO ApS registered with 15% ownership
UGether ApS registered with 15% ownership
KLMBio ApS registered with 15% ownership
Marigold Maturation Fund K/S registered with 20% ownership
Erik Vinther joined the board
Companies in the same industry and area
CVR 38402056
CVR 39859173
CVR 39880377
CVR 43432583
CVR 43575627
Compared to 130 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
companydata.dk